COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASSHASLAM PL; TOWNSEND PJ; BRANTHWAITE MA et al.1980; ANAESTHESIA; GBR; DA. 1980; VOL. 35; NO 1; PP. 22-26; BIBL. 7 REF.Article

CRYPTOGENIC FIBROSING ALVEOLITIS: PREDICTION OF FIBROGENIC ACTIVITY FROM IMMUNOHISTOCHEMICAL STUDIES OF COLLAGEN TYPES IN LUNG BIOPSY SPECIMENSBATEMAN ED; TURNER WARWICK M; HASLAM PL et al.1983; THORAX; ISSN 0040-6376; GBR; DA. 1983; VOL. 38; NO 2; PP. 93-101; BIBL. 30 REF.Article

CARACTERISTIQUES CLINIQUES ET IMMUNOLOGIQUES DE MALADES ATTEINTS D'ALVEOLITE CHRONIQUE FIBROSANTE ASSOCIEE A UNE VASCULITE DIGITALEHODSON ME; HASLAM PL; SPIRO SG et al.1980; REV. FR. MAL. RESP.; FRA; DA. 1980; VOL. 8; NO 1; PP. 77; BIBL. 2 REF.Article

LYMPHOCYTE RESPONSES TO PHYTOHAEMAGGLUTININ IN PATIENTS WITH ASBESTOSIS AND PLEURAL MESOTHELIOMA.HASLAM PL; LUKOSZEK A; MERCHANT JA et al.1978; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1978; VOL. 31; NO 2; PP. 178-188; BIBL. 1 P.Article

CIRCULATING IMMUNE COMPLEXES IN PATIENTS WITH CRYPTOGENIC FIBROSING ALVEOLITISHASLAM PL; THOMPSON B; MOHAMMED I et al.1979; CLIN. EXPER. IMMUNOL.; GBR; DA. 1979; VOL. 37; NO 3; PP. 381-390; BIBL. 2 P.Article

BRONCHOALVEOLAR LAVAGE IN PULMONARY FIBROSIS: COMPARISON OF CELLS OBTAINED WITH LUNG BIOPSY AND CLINICAL FEATURESHASLAM PL; TURTON CWG; HEARD B et al.1980; THORAX; GBR; DA. 1980; VOL. 35; NO 1; PP. 9-18; BIBL. 16 REF.Article

CELLS, ENZYMES AND INTERSTITIAL LUNG DISEASE. THE PHILIP ELLMAN LECTURETURNER WARWICK M; HASLAM PL; LUKOSZEK A et al.1981; J. R. COLL. PHYSICIANS LOND.; ISSN 0035-8819; GBR; DA. 1981; VOL. 15; NO 1; PP. 5-16; 9 P.; BIBL. 51 REF.Article

INTERSTITIAL LUNG DISEASE AND ASTHMA IN HARD-METAL WORKERS: BRONCHOALVEOLAR LAVAGE, ULTRASTRUCTURAL, AND ANALYTICAL FINDINGS AND RESULTS OF BRONCHIAL PROVOCATION TESTSDAVISON AG; HASLAM PL; CORRIN B et al.1983; THORAX; ISSN 0040-6376; GBR; DA. 1983; VOL. 38; NO 2; PP. 119-128; BIBL. 29 REF.Article